Lumexa Imaging (LMRI) vs TriSalus Life Sciences (TLSI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Lumexa Imaging is the larger company by market cap ($1.01 billion vs $250.0 million), about 4.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LMRI | TLSI |
|---|---|---|
| Share price | $10.54 | $4.06 |
| Market cap | $1.01B | $249.99M |
| 1-day change | +2.03% | -1.69% |
| YTD return | -43.03% | -40.83% |
| 1-year return | — | -14.85% |
| 5-year return | — | -58.28% |
| Forward P/E | 11.84 | — |
| EPS (TTM) | $-0.37 | $-1.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.45 | $7.95 |
| 52-week low | $6.45 | $2.20 |
| Distance from 52-week high | -45.81% | -48.93% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +67.65% | +156.16% |
| Average volume | 430.76K | 275.38K |
| Shares outstanding | 96.07M | 61.57M |
| Employees | 5,000 | 102 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Lumexa Imaging is about 4.1 times larger than TriSalus Life Sciences by market value ($1.01B vs $249.99M).
About Lumexa Imaging
LMRI stock →Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States.
Health Care · Medical Specialities · 5,000 employees
About TriSalus Life Sciences
TLSI stock →TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States.
Health Care · Medical Specialities · 102 employees
LMRI vs TLSI FAQ
Which is bigger, Lumexa Imaging or TriSalus Life Sciences?
Lumexa Imaging (LMRI) is larger, with a market capitalization of $1.01B compared with $249.99M for TriSalus Life Sciences (TLSI).
Are Lumexa Imaging and TriSalus Life Sciences in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.